Skip to main content
Clinical Trials/NL-OMON33334
NL-OMON33334
Completed
Phase 3

Evaluation of Indocyanine Green (ICG) enhanced Near-InfraRed Fluorescence (NIRF) Imaging for Intra-Operative Sentinel Lymph Node (SLN) detection in Breast Surgery. - Sentinel node detection with ICG enhanced NIRF optical imaging.

niversitair Medisch Centrum Groningen0 sites150 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
breast cancer
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
150
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women above the age of 21 who have biopsy\-proven breast cancer stage I\-II, and who are undergoing sentinel lymph node mapping for staging and treatment of their disease.

Exclusion Criteria

  • Pregnant women, hyperthyroidism, significant renal (serum creatinin \>\= 400 µmol/L), cardiac or pulmonary disease (ASA III\-IV), history of iodine allergy or analfylactic reaction to insect bites or medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials